ImPact Biotech

ImPact Biotech is an Israeli biotechnology organization spun off from Steba Biotech, operating in the EU, Israel, and the United States. ImPact Biotech focuses on developing a minimally invasive novel oncology platform for treating a range of solid tumors using Padeliporfin VTP (Vascular Targeted Photodynamic Therapy). ImPact Biotech is implementing a bold strategy focused on a series of solid tumors with high medical needs, such as UTUC, NSCLC, and pancreatic cancer. ImPact Biotech has established close cooperation with the Memorial Sloan Kettering Cancer Center in Israel, achieving exciting early results across various types of solid tumors, including UTUC, esophageal cancer, lung cancer, and now pancreatic cancer.